Skip to main content

Advertisement

SpringerLink
Log in

Identification of differentially expressed proteins in chemotherapy-sensitive and chemotherapy-resistant diffuse large B cell lymphoma by proteomic methods

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

An Erratum to this article was published on 22 August 2013

Abstract

In the present study, we employed proteomic methods to identify and quantitate differentially expressed proteins between diffuse large B cell lymphoma (DLBCL) tissues with low and high sensitivity to combinatorial cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy and explored protein networks associated with DLBCL chemoresistance to CHOP. For proteomics analysis, DLBCL tissues were collected from 14 untreated patients. Two-dimensional gel electrophoresis combined with mass spectrometry (MS) were employed to identify and quantitate differentially expressed proteins in DLBCL tissues with low or high sensitivity to CHOP chemotherapy in vitro. Nineteen proteins showing an over twofold change in the MS/MS ions score between the low sensitivity and the high sensitivity groups were identified as differentially expressed proteins and confirmed by Western blot analyses. Immunohistochemical analyses were performed in DLBCL tissue samples from 98 patients who had received four cycles of CHOP chemotherapy, which showed that expressions of the identified CHOP sensitivity biomarkers were significantly associated with therapeutic outcomes of DLBCL, suggesting that the biomarkers could be used to predict DLBCL patient outcomes. This study provides important insights into understanding the molecular basis for development of multi-drug chemoresistance in DLBCL, which may serve as a basis for identification of novel therapeutic targets and biomarkers involved in the emergence and maintenance of DLBCL resistance to CHOP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Cultrera JL, Dalia SM. Diffuse large B-cell lymphoma: current strategies and future directions. Cancer Control. 2012;19:204–13.

    PubMed  Google Scholar 

  2. Nedomova R, Papajik T, Prochazka V, Indrak K, Jarosova M. Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL). Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012; doi:10.5507/bp.2012.085.

  3. Maxwell SA, Li Z, Jaya D, Ballard S, Ferrell J, Fu H. 14–3-3 epsilon mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen. J Biol Chem. 2009;284:22379–89.

    Article  PubMed  CAS  Google Scholar 

  4. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC, Golub TR. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002;8:68–74.

    Article  PubMed  CAS  Google Scholar 

  5. Chance MR, Chang J, Liu S, Gokulrangan G, Chen DH, Lindsay A, Geng R, Zheng QY, Alagramam K. Proteomics, bioinformatics and targeted gene expression analysis reveals up-regulation of cochlin and identifies other potential biomarkers in the mouse model for deafness in Usher syndrome type 1F. Hum Mol Genet. 2010;19:1515–27.

    Article  PubMed  CAS  Google Scholar 

  6. Bortner JD, Richie JP, Das A, Liao J, Umstead TM, Stanley A, Stanley BA, Belani CP, El-Bayoumy K. Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking. J Proteome Res. 2011;10:1151–9.

    Article  PubMed  CAS  Google Scholar 

  7. Liu Y, Teng X, Yang X, Song Q, Lu R, Xiong J, Liu B, Zeng N, Zeng Y, Long J, Cao R, Lin Y, He Q, Chen P, Lu M, Liang S. Shotgun proteomics and network analysis between plasma membrane and extracellular matrix proteins from rat olfactory ensheathing cells. Cell Transpl. 2010;19:133–46.

    Article  Google Scholar 

  8. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-López A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP. Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. J Clin Oncol. 1999;17:1244–53.

    PubMed  CAS  Google Scholar 

  9. Zhu H, Pei HP, Zeng S, Chen J, Shen LF, Zhong MZ, Yao RJ, Shen H. Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma. J Proteome Res. 2009;8:3969–76.

    Article  PubMed  CAS  Google Scholar 

  10. Lv XG, Ji MY, Dong WG, Lei XF, Liu M, Guo XF, Wang J, Fang C. EBP50 gene transfection promotes 5-fluorouracil-induced apoptosis in gastric cancer cells through Bax- and Bcl-2-triggered mitochondrial pathways. Mol Med Report. 2012;5:1220–6.

    CAS  Google Scholar 

  11. Fan NJ, Gao CF, Wang CS, Zhao G, Lv JJ, Wang XL, Chu GH, Yin J, Li DH, Chen X, Yuan XT, Meng NL. Identification of the up-regulation of TP-alpha, collagen alpha-1(VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method. J Proteomics. 2012;75:3977–86.

    Article  PubMed  CAS  Google Scholar 

  12. Pyo JS, Roh SH, Kim DK, Lee JG, Lee YY, Hong SS, Kwon SW, Park JH. Anti-cancer effect of Betulin on a human lung cancer cell line: a pharmacoproteomic approach using 2 D SDS PAGE coupled with nano-HPLC tandem Mass Spectrometry. Planta Med. 2009;75:127–31.

    Article  PubMed  CAS  Google Scholar 

  13. Wu K, Wang X, Xie Z, Liu Z, Lu Y. Glutathione S-transferase P1 gene polymorphism and bladder cancer susceptibility: an updated analysis. Mol Biol Rep. 2013;40:687–95.

    Article  PubMed  CAS  Google Scholar 

  14. Vasiljević N, Ahmad AS, Beesley C, Thorat MA, Fisher G, Berney DM, Møller H, Yu Y, Lu YJ, Cuzick J, Foster CS, Lorincz AT. Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer. Prostate Cancer Prostatic Dis. 2012;. doi:10.1038/pcan.2012.47.

    PubMed  Google Scholar 

  15. Tang S, Huang W, Zhong M, Yin L, Jiang H, Hou S, Gan P, Yuan Y. Identification Keratin 1 as a cDDP-resistant protein in nasopharyngeal carcinoma cell lines. J Proteomics. 2012;75:2352–60.

    Article  PubMed  CAS  Google Scholar 

  16. Guo JP, Coppola D, Cheng JQ. IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation. J Biol Chem. 2011;286:37389–98.

    Article  PubMed  CAS  Google Scholar 

  17. Okada S, Suzuki K, Takaharu K, Noda H, Kamiyama H, Maeda T, Saito M, Koizumi K, Miyaki Y, Konishi F. Aberrant methylation of the pleckstrin and Sec7 domain-containing gene is implicated in ulcerative colitis-associated carcinogenesis through its inhibitory effect on apoptosis. Int J Oncol. 2012;40:686–94.

    PubMed  CAS  Google Scholar 

  18. Borst P, Jonkers J, Rottenberg S. What makes tumor multidrug resistance? Cell Cycle. 2007;6:2782–7.

    Article  PubMed  CAS  Google Scholar 

  19. Backos DS, Franklin CC, Reigan P. The role of glutathione in brain tumor drug resistance. Biochem Pharmacol. 2012;83:1005–12.

    Article  PubMed  CAS  Google Scholar 

  20. Romero A, Martín M, Oliva B, de la Torre J, Furio V, de la Hoya M, García-Sáenz JA, Moreno A, Román JM, Diaz-Rubio E, Caldés T. Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients. Ann Oncol. 2012;23:1750–6.

    Article  PubMed  CAS  Google Scholar 

  21. Wang YC, Yo YT, Lee HY, Liao YP, Chao TK, Su PH, Lai HC. ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome. Am J Pathol. 2012;180:1159–69.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by Doctoral Training Foundation of Ministry of Education, P.R. China (Grant #2.00902E+13).

Conflict of interest

The author(s) declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Oncology, Xiangya Hospital, Central South University, 88 Xiangya Road, Changsha, 410008, Hunan, People’s Republic of China

    Yiping Liu, Shan Zeng, Jin Huang, Youhong Tang & Meizuo Zhong

  2. Department of Pathology, Xiangya School of Medicine, Central South University, Changsha, 410008, People’s Republic of China

    Liang Zeng

  3. Department of Oncology, The Eighth Hospital of Changsha, Changsha, 410100, People’s Republic of China

    Shusheng Zhang

Authors
  1. Yiping Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liang Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shusheng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shan Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jin Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Youhong Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Meizuo Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Meizuo Zhong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Y., Zeng, L., Zhang, S. et al. Identification of differentially expressed proteins in chemotherapy-sensitive and chemotherapy-resistant diffuse large B cell lymphoma by proteomic methods. Med Oncol 30, 528 (2013). https://doi.org/10.1007/s12032-013-0528-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0528-5

Keywords

Search

Navigation